Endonovo Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Stock Symbol
  • ENDV

Stock Symbol

  • Investments
  • 6

Endonovo Therapeutics General Information

Description

Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.

Contact Information

Formerly Known As
Hanover Asset Management, Hanover Portfolio Acquisitions, Inc.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 6320 Canoga Avenue
  • 15th Floor, Woodland Hills
  • Los Angeles, CA 91367
  • United States
+1 (877)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
OTCM
Vertical(s)
Corporate Office
  • 6320 Canoga Avenue
  • 15th Floor, Woodland Hills
  • Los Angeles, CA 91367
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endonovo Therapeutics Stock Performance

As of 09-Nov-2026, Endonovo Therapeutics’s current market cap is $181K with 1.81B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$181K 1.81B 711K

Endonovo Therapeutics Financials Summary

As of 30-Jun-2025, Endonovo Therapeutics has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 7,045 7,175 9,830 10,715
Revenue 0 10 140 135
EBITDA (925) (941) 8,854 (16,506)
Net Income (2,458) (2,797) 6,925 (18,475)
Total Assets 18 18 638 1,281
Total Debt 6,896 6,870 7,073 7,153
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Endonovo Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Endonovo Therapeutics‘s full profile, request access.

Request a free trial

Endonovo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Elect
Biotechnology
Los Angeles, CA

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Endonovo Therapeutics Competitors (1)

One of Endonovo Therapeutics’s competitors is Achaogen, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Achaogen Formerly VC-backed South San Francisco, CA
You’re viewing 1 of 1 competitors. Get the full list »

Endonovo Therapeutics Patents

Endonovo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018156919-A1 Devices and methods for the delivery of non-thermal therapeutic and prophylactic pulsed electromagnetic fields from a mobile communications device Inactive 24-Feb-2017
EP-3272854-A1 Biological molecules produced by electromagnetically stimulating living mammalian cells Inactive 21-Jul-2016
JP-2018007647-A Biological molecules produced by electromagnetically stimulating living mammalian cells Pending 15-Jul-2016
US-20170186346-A1 Adaptable tensioned-fabric framing system Inactive 29-Dec-2015
US-20190351249-A1 Method and apparatus for electromagnetic treatment of living systems Inactive 04-Nov-2014 A61N2/008
To view Endonovo Therapeutics’s complete patent history, request access »

Endonovo Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Endonovo Therapeutics‘s full profile, request access.

Request a free trial

Endonovo Therapeutics Investments & Acquisitions (6)

Endonovo Therapeutics’s most recent deal was a Merger/Acquisition with Western Star Concrete. The deal was made on 01-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Western Star Concrete 01-Mar-2023 Merger/Acquisition Construction and Engineering
Rio Grande Neurosciences 27-Dec-2017 Merger/Acquisition Therapeutic Devices
Rio Grande Neurosciences (Pulsed Electromagnetic Field Therapy Assets) 22-Dec-2017 Corporate Asset Purchase Buildings and Property
WeHealAnimals 16-Nov-2013 Merger/Acquisition Other Pharmaceuticals and Biotechnology
The Aviva Companies 09-Apr-2013 Merger/Acquisition Other Commercial Services
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Endonovo Therapeutics ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Endonovo Therapeutics’s complete esg history, request access »

Endonovo Therapeutics FAQs

  • When was Endonovo Therapeutics founded?

    Endonovo Therapeutics was founded in 2008.

  • Where is Endonovo Therapeutics headquartered?

    Endonovo Therapeutics is headquartered in Los Angeles, CA.

  • What industry is Endonovo Therapeutics in?

    Endonovo Therapeutics’s primary industry is Biotechnology.

  • Is Endonovo Therapeutics a private or public company?

    Endonovo Therapeutics is a Public company.

  • What is Endonovo Therapeutics’s stock symbol?

    The ticker symbol for Endonovo Therapeutics is ENDV.

  • What is the current market cap of Endonovo Therapeutics?

    The current market capitalization of Endonovo Therapeutics is $181K.

  • Who are Endonovo Therapeutics’s competitors?

    Achaogen is a competitor of Endonovo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process